Hodgkin Lymphoma Treatment Everyday Health MenuNewslettersSearch Lymphoma Hodgkin Lymphoma Treatment By Lindsey KonkelMedically Reviewed by Robert Jasmer, MDReviewed: July 29, 2015Medically ReviewedTreatments for this form of blood cancer have a high rate of success. Hodgkin lymphoma is a type of blood cancer that affects the lymph system. In people with Hodgkin lymphoma, a cancerous tumor develops in a lymph node. Lymph nodes are small, bean-shaped organs that make immune cells to help the body fight infections. The treatment plan your doctor recommends for Hodgkin lymphoma will depend on the stage of your cancer, or how far from the lymph node the cancer has spread. The two main treatments for Hodgkin lymphoma are chemotherapy and radiation therapy. Chemotherapy for Hodgkin Lymphoma Chemotherapy, also called chemo, is the use of medications to destroy existing cancer cells and to stop the growth of new cancer cells. Some chemotherapy drugs are given orally. Other drugs may be given by intravenous (IV) injection. Your doctor may prescribe a combination of anticancer drugs. This is called a treatment regimen. Chemotherapy regimens for Hodgkin lymphoma may vary depending on a number of factors, including how far the cancer has spread. The most commonly used regimen for Hodgkin lymphoma is called ABVD. ABVD includes four anticancer drugs:Adriamycin (doxorubicin)BleomycinVinblastineDacarbazine Chemotherapy is typically given in cycles. During a chemo cycle, you may be given several days to recover between treatments. You may have to go to a clinic or hospital on treatment days if you're receiving IV chemo drugs. Chemotherapy often causes side effects, the type and severity of which depend on the types and doses of drugs used. Common side effects include:Hair lossNausea and vomitingFatigue or extreme tirednessLoss of appetiteBleeding or becoming bruised easilyHigher risk of infections Radiation Therapy For Hodgkin Lymphoma Radiation therapy uses high-energy beams of X-rays to kill cancer cells. If your doctor recommends radiation therapy for Hodgkin lymphoma, treatment will usually begin after you've completed chemotherapy. In radiation therapy, X-ray beams are focused on the lymph node or cancerous area. It's usually given in small doses over a period of weeks to help reduce side effects. Common side effects of radiation therapy for Hodgkin lymphoma include:Skin changes in the area that was treated (may look like sunburn)FatigueNausea Bone Marrow Transplants for Hodgkin Lymphoma A bone marrow transplant, sometimes also called a stem cell transplant, may be used to treat Hodgkin lymphoma that returns after the initial treatment. Doctors sometimes need to use very high doses of chemotherapy drugs and radiation to kill cancer cells. These treatments can be very effective at killing the cancer cells, but they may also destroy the bone marrow, where new blood cells grow. Stem cells taken from healthy blood or bone marrow may be transplanted to replace these damaged cells. Sometimes the stem cells come from someone else (a donor). Clinical Trials for Hodgkin Lymphoma Clinical trials — research studies in people — may test new treatments for Hodgkin lymphoma or new combinations of treatments that are already in use. Clinical trials help determine whether new treatments are safe and effective, and whether they work better than current treatments. By participating in a clinical trial, you may be able to receive a new drug or treatment that you wouldn't otherwise be able to receive. Most people find out about clinical trials through their doctors. You can also find a list of clinical trials sponsored by the National Cancer Institute at www.cancer.gov/clinicaltrials. NEWSLETTERS Sign up for our Cancer Care Newsletter SubscribeBy subscribing you agree to the Terms of Use and Privacy Policy. Editorial Sources and Fact-Checking Adult Hodgkin Lymphoma Treatment: Treatment Option Overview; National Cancer Institute.Patient information: Hodgkin lymphoma treatment; UpToDate.Show Less The Latest in Lymphoma Small Lymphocytic Lymphoma SLL Treatment Stages PrognosisBy Julie Lynn MarksSeptember 19, 2022 Surviving Cancer From Teenage Diagnosis to Elite Athlete and CoachLottie Mishan was just 14 when she was diagnosed with Hodgkin lymphoma and had no role models to show her what survival could look like. Now, she’s that...By Leona VaughnAugust 26, 2022 Spotlight On The Leukemia and Lymphoma SocietyThe Leukemia and Lymphoma Society’s mission is to help educate and support people with blood cancer, and provide funding for new research. By Leona VaughnAugust 26, 2022 New Drug Combination May Be Game-Changer for Non-Hodgkin Lymphoma PatientsAdding ibrutinib (Imbruvica) could be the new standard for treating rare mantle cell lymphoma in older patients.By Susan K. TreimanJune 6, 2022 Lymphoma Resources Finding the Help You NeedIf you’ve recently been diagnosed with a lymphoma, it’s important to have access to resources that can help you understand, cope, and recover from your...By Nicol NataleOctober 14, 2021 Diagnosing Lymphoma What Can I Expect By Julie Lynn MarksOctober 14, 2021 What Is Follicular Lymphoma Treatment Prognosis Symptoms Causes and MoreBy Ashley WelchOctober 14, 2021 What I Learned When My Husband Got a Rare Cancer February 28 is Rare Disease Day; one woman shares what she learned when her 30-year-old husband faced an aggressive rare cancer.By Susanne KatusFebruary 27, 2019 After the Cure Survival Rates for Lymphomas Are High but Patients Need to Consider Long-Term EffectsThere are very few cancers for which doctors will use the word 'cure' right off the bat, but Hodgkin lymphoma (HL), the most common cancer diagnosis among...By Paula DerrowApril 26, 2018 New Study Sheds Light on Genetic Differences in Types of LymphomaThe research could help steer patients to more appropriate treatments based on the genetic underpinnings of their disease.By Shari RoanApril 20, 2018 MORE IN When Non-Small-Cell Lung Cancer Spreads What to Expect What Is Merkel Cell Carcinoma Symptoms Causes Diagnosis Treatment and Prevention 8 Things to Know About Targeted Therapies for Metastatic Non-Small-Cell Lung Cancer